COMMUNIQUÉS West-GlobeNewswire

Beta Bionics and Zealand Pharma initiate home-use trial of the iLet™ bionic pancreas with dasiglucagon for autonomous bihormonal treatment of Type 1 diabetes
22/05/2019
Zealand Pharma Press Release – No. 11 / 2019 Beta Bionics and Zealand Pharma initiate home-use trial of the iLet™ bionic pancreas with dasiglucagon for autonomous bihormonal treatment of Type 1 diabetes First home-use [...]
Tauriga Sciences Inc. Invited to Present at The MJ Micro Conference on June 25, 2019 at the Westin Grand Central Hotel in Midtown Manhattan
22/05/2019
New York, NY, May 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and [...]
Avadel Pharmaceuticals Announces FDA Acceptance of New Drug Application for AV001
22/05/2019
AV001 granted Priority Review PDUFA action date is September 15, 2019 DUBLIN, Ireland, May 22, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), today announced that the U.S. Food and Drug [...]
Establishment Labs Holdings Inc. and Allergan Sales, LLC Extend Distribution and Supply Agreement for MotivaImagine® Insertion Sleeve
22/05/2019
NEW YORK, May 22, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today [...]
Alimera Sciences Announces Launch of Direct-to-Patient Marketing Campaign to Raise Awareness and Educate Consumers on Diabetic Macular Edema and ILUVIEN®
22/05/2019
Pilot program to be initiated in four U.S. cities leveraging radio, print and social media channels, with potential for future expansion ILUVIEN’s CONTINUOUS MICRODOSING™ delivery enables patients diagnosed with [...]
Teewinot Life Sciences Announces Executive Leadership Changes
22/05/2019
New management team brings decades of experience in leadership and operational management of drug development and manufacturing, including the financial transition of companies from private to public markets TAMPA, Fla [...]
Affimed Announces R&D Strategy to Focus on Innate Immunity Portfolio; Reports First Quarter 2019 Financial Results and Operational Progress
22/05/2019
- Company to focus on the development of AFM13, AFM24 and preclinical innate cell engagers, decides to terminate AFM11 T cell engager Phase 1 program - - Received milestone payment from Genentech, continuing to [...]
Mois de l’activité physique
22/05/2019
Des risques majeurs pour la santé liés à la sédentarité MONTRÉAL, 22 mai 2019 (GLOBE NEWSWIRE) -- Dans le cadre du mois de l’activité physique , la Fondation de l’Institut de Cardiologie de Montréal fait le point sur la [...]
CURE Pharmaceutical Secures Patent on Oral Thin Film Containing Bioactive Cannabinoid Molecules
22/05/2019
OXNARD, Calif., May 22, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the issuance of U.S. Patent No. 10,307,397, which covers the high [...]
Sol-Gel Technologies Reports First Quarter 2019 Financial Results and Corporate Update
22/05/2019
Top-line results from Phase III Epsolay ® and TWIN trials remain on track; mid-2019 and 4Q19, respectfully Reports top-line generic product revenues of $6.3 million NESS ZIONA, Israel, May 22, 2019 (GLOBE NEWSWIRE) -- [...]
Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla®
22/05/2019
FDA Assigns Prescription Drug User Fee Act (PDUFA) Goal Date of November 16, 2019 PRINCETON, N.J., May 22, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women’s healthcare company, today announced [...]
BrainsWay Announces its Multicenter Smoking Cessation Study Has Reached Target Enrollment
22/05/2019
More than 260 participants have been enrolled to the study JERUSALEM, Israel and HACKENSACK, N.J., May 22, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”) today announced it reached [...]
Nabriva Therapeutics to Present at the Jefferies 2019 Healthcare Conference
22/05/2019
DUBLIN, Ireland and KING OF PRUSSIA, Pa., May 22, 2019 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the development of innovative anti-infective agents to treat [...]
Emerald Health Therapeutics Appoints Chief Operating Officer
22/05/2019
Sean Rathbone brings extensive expertise in capital projects, operational leadership and corporate process management VICTORIA, British Columbia, May 22, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (" [...]
HEXO strengthens leadership team, appoints Donald Courtney as Chief Operating Officer
22/05/2019
GATINEAU, Quebec, May 22, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE-A: HEXO) is further strengthening its leadership team by appointing Donald Courtney as Chief Operating Officer. “I [...]
HEXO renforce son équipe de direction et nomme Donald Courtney au poste de directeur principal de l’exploitation
22/05/2019
GATINEAU, Québec, 22 mai 2019 (GLOBE NEWSWIRE) -- HEXO Corp (« HEXO » ou la « Société ») (TSX : HEXO ; NYSE-A : HEXO) renforce davantage son équipe de direction en nommant Donald Courtney au poste de directeur principal [...]
RavenQuest BioMed Expands Into Europe
22/05/2019
VANCOUVER, British Columbia, May 22, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT1) (the “ Company ” or “ RavenQuest ”) is pleased to announce that it has signed a Heads of [...]
Lundbeck increases its share capital by 26,098 shares (0.0131 % of outstanding shares) as a result of exercise of employee warrants
22/05/2019
Valby, Denmark, 22 May 2019 - H. Lundbeck A/S (Lundbeck) today announced that it has decided to increase its share capital by DKK 130,490 as a consequence of the exercise of employee warrants. The increase is effected [...]
Results Announced from Two Renal Denervation Studies at EuroPCR Show Positive Outcomes in High-Risk Hypertensive Patients
22/05/2019
Late-Breaking Clinical Trial Results and Updated Global SYMPLICITY Registry Data Demonstrate Long-Term Results of RDN for Uncontrolled Hypertension DUBLIN and PARIS - May 22, 2019 - Investigators today unveiled late- [...]

Pages